Comparitive study of therapeutic effects of labetalol with methyldopa in hypertension in pregnancy induced hypertension and fetal outcome

In a country like India, where maternal mortality rate is still very high despite progress and development which has consistently been made in the health services, big proportion deprived of it. Hypertension most common medical problem encountered during pregnancy. This study was undertaken to compare efficacy labetalol versus methyldopa treatment pre-eclampsia prevention further complications. The present had carried out on antenatal booked 110 cases between 20 – 40 years age who developed hypertension after weeks period gestation with or without oedema & proteinuria both, attending OPD Emergency at Govt General Hospital, Nizamabad, from 1st December 2017 31may 2018. : Incidence PIH 7.23% population. Side effects drugs were reported more group as compared labetalol. Adverse foetal outcomes, especially IUGR pre term babies are group. lscs 14 55 group,22 noted. Most indication for emergency LSCS both groups uncontrolled hypertension, but Labetalol 7 underwent EL LSCS, 6 LSCS. Total no caesarean sections 21 55(32.7%),whereas group28 (50.9%), so operative interference when It concludes that suitable use pregnancy reduce fetal side-effects, it efficient hypotensive action.